Skip to content
The Policy VaultThe Policy Vault

Nayzilam (midazolam nasal spray)Medica

intermittent episodes of frequent seizure activity (seizure clusters, acute repetitive seizures)

Initial criteria

  • Patient is currently receiving maintenance antiseizure medication(s)
  • Medication is prescribed by or in consultation with a neurologist

Approval duration

1 year